Androgen receptor-induced integrin α6β1 and Bnip3 promote survival and resistance to PI3K inhibitors in castration-resistant prostate cancer
- 21 June 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 39 (31), 5390-5404
- https://doi.org/10.1038/s41388-020-1370-9
Abstract
The androgen receptor (AR) is the major driver of prostate cancer growth and survival. However, almost all patients relapse with castration-resistant disease (CRPC) when treated with anti-androgen therapy. In CRPC, AR is often aberrantly activated independent of androgen. Targeting survival pathways downstream of AR could be a viable strategy to overcome CRPC. Surprisingly, little is known about how AR drives prostate cancer survival. Furthermore, CRPC tumors in which Pten is lost are also resistant to eradication by PI3K inhibitors. We sought to identify the mechanism by which AR drives tumor survival in CRPC to identify ways to overcome resistance to PI3K inhibition. We found that integrins α6β1 and Bnip3 are selectively elevated in CRPC downstream of AR. While integrin α6 promotes survival and is a direct transcriptional target of AR, the ability of AR to induce Bnip3 is dependent on adhesion to laminin and integrin α6β1-dependent nuclear translocation of HIF1α. Integrins α6β1 and Bnip3 were found to promote survival of CRPC cells selectively on laminin through the induction of autophagy and mitophagy. Furthermore, blocking Bnip3 or integrin α6β1 restored sensitivity to PI3K inhibitors in Pten-negative CRPC. We identified an AR driven pathway that cooperates with laminin and hypoxia to drive resistance to PI3K inhibitors. These findings can help explain in part why PI3K inhibitors have failed in clinical trials to overcome AR-dependent CRPC.Funding Information
- U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (R01CA154835, P30CA023074, R01CA154835, R01CA159406)
- U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute
- U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute
- U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute
- U.S. Department of Health & Human Services | NIH | Center for Information Technology (P30CA023074)
This publication has 59 references indexed in Scilit:
- BNip3 Regulates Mitochondrial Function and Lipid Metabolism in the LiverMolecular and Cellular Biology, 2012
- Microtubule-associated Protein 1 Light Chain 3 (LC3) Interacts with Bnip3 Protein to Selectively Remove Endoplasmic Reticulum and Mitochondria via AutophagyJournal of Biological Chemistry, 2012
- Hypoxia-Induced Autophagy Is Mediated through Hypoxia-Inducible Factor Induction of BNIP3 and BNIP3L via Their BH3 DomainsMolecular and Cellular Biology, 2009
- Role of BNIP3 and NIX in cell death, autophagy, and mitophagyCell Death & Differentiation, 2009
- Antagonism of E2F-1 regulated Bnip3 transcription by NF-κB is essential for basal cell survivalProceedings of the National Academy of Sciences of the United States of America, 2008
- Regulation of hypoxia-inducible factor-1α by NF-κBBiochemical Journal, 2008
- Mitochondrial redox signaling by p66Shc is involved in regulating androgenic growth stimulation of human prostate cancer cellsOncogene, 2008
- Induction of Autophagy during Extracellular Matrix Detachment Promotes Cell SurvivalMolecular Biology of the Cell, 2008
- Human ORFeome Version 1.1: A Platform for Reverse ProteomicsGenome Research, 2004
- Hypoxia induces the expression of the pro-apoptotic gene BNIP3Cell Death & Differentiation, 2001